32977311000001103: Trifluridine 15mg / Tipiracil 6.14mg tablets (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Trifluridine 15mg / Tipiracil 6.14mg tablets
\UK product\Virtual therapeutic moiety\Trifluridine + Tipiracil\Trifluridine 15mg / Tipiracil 6.14mg tablets

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing glycosyltransferase inhibitor\Product containing pentosyltransferase inhibitor\Product containing thymidine phosphorylase inhibitor (product)\Product containing tipiracil and trifluridine\Trifluridine + Tipiracil\Trifluridine 15mg / Tipiracil 6.14mg tablets
\Medicinal product\Medicinal product categorized by disposition\Product containing trifluridine\Product containing tipiracil and trifluridine\Trifluridine + Tipiracil\Trifluridine 15mg / Tipiracil 6.14mg tablets
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrimidine\Product containing tipiracil and trifluridine\Trifluridine + Tipiracil\Trifluridine 15mg / Tipiracil 6.14mg tablets
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrrolidine\Product containing tipiracil and trifluridine\Trifluridine + Tipiracil\Trifluridine 15mg / Tipiracil 6.14mg tablets
\Medicinal product\Medicinal product categorized by structure\Product containing nucleoside analog\Product containing trifluridine\Product containing tipiracil and trifluridine\Trifluridine + Tipiracil\Trifluridine 15mg / Tipiracil 6.14mg tablets
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Product containing trifluridine\Product containing tipiracil and trifluridine\Trifluridine + Tipiracil\Trifluridine 15mg / Tipiracil 6.14mg tablets
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing tipiracil and trifluridine\Trifluridine + Tipiracil\Trifluridine 15mg / Tipiracil 6.14mg tablets

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

100462501000001115 Trifluridine 15mg / Tipiracil 6.14mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

100462601000001116 Trifluridine 15mg / Tipiracil 6.14mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Trifluridine 15mg / Tipiracil 6.14mg tablets	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Oral route	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Discrete dose form indicator	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	tablet.oral ontology form and route	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Is a	Trifluridine + Tipiracil	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Plays role	Antineoplastic therapeutic role	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Plays role	Antiviral therapeutic role	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Is a	Trifluridine + Tipiracil	false	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Has specific active ingredient	Trifluridine	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Has specific active ingredient	Tipiracil hydrochloride	false	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Tipiracil	false	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Has specific active ingredient	Tipiracil hydrochloride	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Has basis of strength substance	Tipiracil	false	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Tipiracil	true	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets	Has active ingredient	Antimetabolite	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Lonsurf 15mg/6.14mg tablets (Servier Laboratories Ltd)	Is a	True	Trifluridine 15mg / Tipiracil 6.14mg tablets	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets 60 tablet	Has VMP	True	Trifluridine 15mg / Tipiracil 6.14mg tablets	Inferred relationship	Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets 20 tablet	Has VMP	True	Trifluridine 15mg / Tipiracil 6.14mg tablets	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
100462501000001115	Trifluridine 15mg / Tipiracil 6.14mg tablets (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
100462601000001116	Trifluridine 15mg / Tipiracil 6.14mg tablets	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module